id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2005-P-0194-0001,FDA,FDA-2005-P-0194,Acknowledgment Letter from FDA DDM to Warren Rucker,Other,Acknowledgement Letter/Receipt,2005-12-30T05:00:00Z,2005,12,,,2018-08-13T15:51:37Z,,0,0,0900006480440eae
FDA-1992-V-0009-0002,FDA,FDA-1992-V-0009,Variance Approval from FDA CDRH to Jeff Cone Studios,Other,Approval for Variance (VRA),2005-12-30T05:00:00Z,2005,12,,,2015-09-25T18:15:32Z,,0,0,0900006480525e9e
FDA-2005-N-0162-0040,FDA,FDA-2005-N-0162,"Transcript of the November 2, 2005 Hearing",Other,TR-Transcript,2005-12-29T05:00:00Z,2005,12,,,2008-04-11T23:50:43Z,,0,0,0900006480440849
FDA-2005-N-0162-0039,FDA,FDA-2005-N-0162,"Transcript of the November 2, 2005 Hearing",Other,TR-Transcript,2005-12-29T05:00:00Z,2005,12,,,2008-04-11T23:50:47Z,,0,0,0900006480440848
FDA-2005-P-0125-0003,FDA,FDA-2005-P-0125,Letter from FDA CDER to James Salsman,Other,LET-Letter,2005-12-28T05:00:00Z,2005,12,,,2024-12-13T20:23:06Z,,0,0,090000648043fc4f
FDA-2005-P-0426-0004,FDA,FDA-2005-P-0426,Acknowledgment Letter from FDA DDM to Sidley Austin Brown & Wood LLP,Other,Acknowledgement Letter/Receipt,2005-12-28T05:00:00Z,2005,12,,,2025-04-25T12:54:24Z,,0,0,0900006480450259
FDA-2005-P-0128-0003,FDA,FDA-2005-P-0128,Letter from FDA CFSAN to Quaker Oats Company,Other,Letter(s),2005-12-28T05:00:00Z,2005,12,,,2025-04-21T13:57:08Z,,0,0,090000648043fcb6
FDA-2005-P-0426-0003,FDA,FDA-2005-P-0426,Acknowledgment Letter from FDA DDM to Sidley Austin Brown & Wood LLP,Other,Acknowledgement Letter/Receipt,2005-12-28T05:00:00Z,2005,12,,,2025-04-25T12:52:39Z,,0,0,0900006480450258
FDA-2005-P-0372-0003,FDA,FDA-2005-P-0372,"Petition Denial from FDA Associate Commissioner for Regulatory Affairs to Bell, Boyd & Lloyd LLC",Other,Denial,2005-12-28T05:00:00Z,2005,12,,,2025-03-14T19:15:35Z,,0,0,090000648044b55d
FDA-2003-P-0072-0007,FDA,FDA-2003-P-0072,FDA Regulations Policy & Management Staff to the Division of Dockets Management - Memorandum,Other,M-Memorandum,2005-12-27T05:00:00Z,2005,12,,,2008-06-02T19:08:15Z,,0,0,0900006480482076
FDA-2003-V-0187-0003,FDA,FDA-2003-V-0187,FDA/CDRH to Heritage Planetarium  - Approval for Variance,Other,VRA-Approval for Variance,2005-12-27T05:00:00Z,2005,12,,,2013-07-27T20:55:15Z,,0,0,090000648048a9fe
FDA-2005-V-0447-0003,FDA,FDA-2005-V-0447,Spectronika Ltd. - Approval for Variance,Other,VRA-Approval for Variance,2005-12-27T05:00:00Z,2005,12,,,2008-10-03T18:11:05Z,,0,0,0900006480450688
FDA-2000-P-0097-0003,FDA,FDA-2000-P-0097,"Memorandum from Regulations & Policy Management Staff to Division of Dockets Management (HFA-305), Dated 12/23/2005",Other,Memorandum,2005-12-27T05:00:00Z,2005,12,,,2021-11-30T15:39:34Z,,0,0,09000064804b828d
FDA-2005-D-0227-0002,FDA,FDA-2005-D-0227,"Guidance for Industry - Questions and Answers Regarding Food Allergens, including the Food Allergen Labeling and Consumer Protection Act of 2004 (Edition 2) - Final Guidance",Other,GDL-Guidance (Supporting and Related Materials),2005-12-27T05:00:00Z,2005,12,2005-12-27T15:46:28Z,,2024-11-12T04:12:33Z,,1,0,0900006480442062
FDA-2005-P-0059-0007,FDA,FDA-2005-P-0059,FDA/CDER to Williams & Connolly LLP,Other,LET-Letter,2005-12-27T05:00:00Z,2005,12,,,2008-04-12T00:07:52Z,,0,0,090000648043f057
FDA-2002-N-0031-0063,FDA,FDA-2002-N-0031,The Honorable Jim Bunning to the Food and Drug Administration - Letter,Other,LET-Letter,2005-12-23T05:00:00Z,2005,12,,,2008-04-23T20:31:09Z,,0,0,090000648048a4b5
FDA-2002-N-0031-0052,FDA,FDA-2002-N-0031,The Honorable John E. Peterson to the Food and Drug Administration - Letter,Other,LET-Letter,2005-12-23T05:00:00Z,2005,12,,,2008-04-23T20:25:01Z,,0,0,090000648048a47f
FDA-2002-N-0031-0051,FDA,FDA-2002-N-0031,The Honorable John E. Peterson to the Food and Drug Administration - Letter,Other,LET-Letter,2005-12-23T05:00:00Z,2005,12,,,2008-04-23T20:23:27Z,,0,0,090000648048a478
FDA-2004-H-0391-0113,FDA,FDA-2004-H-0391,FDA/DDM,Other,CS-Certificate of Service,2005-12-22T05:00:00Z,2005,12,,,2008-04-12T00:37:50Z,,0,0,0900006480474367
FDA-2005-P-0008-0001,FDA,FDA-2005-P-0008,Number not used,Other,ACK-Acknowledgement Letter,2005-12-22T05:00:00Z,2005,12,,,2008-04-12T00:07:27Z,,0,0,090000648043e3b8
FDA-2004-H-0391-0115,FDA,FDA-2004-H-0391,FDA/DDM,Other,CS-Certificate of Service,2005-12-22T05:00:00Z,2005,12,,,2008-04-12T00:37:51Z,,0,0,0900006480474369
FDA-2005-P-0436-0003,FDA,FDA-2005-P-0436,number not used,Other,ACK-Acknowledgement Letter,2005-12-21T05:00:00Z,2005,12,,,2008-04-12T00:10:37Z,,0,0,090000648045046d
FDA-2005-P-0057-0003,FDA,FDA-2005-P-0057,"Acknowledgment Letter from FDA DDM to Hyman, Phelps & McNamara, P.C",Other,Acknowledgement Letter/Receipt,2005-12-21T05:00:00Z,2005,12,,,2025-04-24T16:28:00Z,,0,0,090000648043ee1c
FDA-2005-P-0057-0002,FDA,FDA-2005-P-0057,"Acknowledgment Letter from FDA DDM to Hyman, Phelps & McNamara, P.C",Other,Acknowledgement Letter/Receipt,2005-12-21T05:00:00Z,2005,12,,,2025-04-24T16:26:37Z,,0,0,090000648043ee1b
FDA-2005-P-0057-0001,FDA,FDA-2005-P-0057,"Acknowledgment Letter from FDA DDM to Hyman, Phelps & McNamara, P.C",Other,Acknowledgement Letter/Receipt,2005-12-21T05:00:00Z,2005,12,,,2025-04-24T16:25:27Z,,0,0,090000648043ee10
FDA-2005-V-0452-0002,FDA,FDA-2005-V-0452,Acknowledgement Letter to Night Vision Equipment Company,Other,Acknowledgement Letter/Receipt,2005-12-21T05:00:00Z,2005,12,,,2025-11-06T02:29:53Z,,0,0,09000064804507b5
FDA-2005-V-0452-0001,FDA,FDA-2005-V-0452,Duplicate - Acknowledgement Letter to Night Vision Equipment Company,Other,Acknowledgement Letter/Receipt,2005-12-21T05:00:00Z,2005,12,,,2025-11-06T02:29:00Z,,0,0,09000064804507b0
FDA-2005-N-0040-0005,FDA,FDA-2005-N-0040,"Agenda for November 17, 2005 Stakeholder Meeting",Other,LST-List,2005-12-20T05:00:00Z,2005,12,,,2008-04-11T23:49:32Z,,0,0,090000648043eab4
FDA-2005-P-0133-0001,FDA,FDA-2005-P-0133,HFA-305 to Mayne Pharma (USA) Inc.,Other,ACK-Acknowledgement Letter,2005-12-20T05:00:00Z,2005,12,,,2008-04-12T00:08:30Z,,0,0,090000648043fe0e
FDA-2005-P-0133-0002,FDA,FDA-2005-P-0133,HFA-305 to Mayne Pharma (USA) Inc.,Other,ACK-Acknowledgement Letter,2005-12-20T05:00:00Z,2005,12,,,2008-04-12T00:08:30Z,,0,0,090000648043fe15
FDA-2005-P-0436-0001,FDA,FDA-2005-P-0436,"HFA-305 to Vigconic (International), Ltd.",Other,ACK-Acknowledgement Letter,2005-12-20T05:00:00Z,2005,12,,,2008-04-12T00:10:37Z,,0,0,0900006480450443
FDA-2005-P-0436-0002,FDA,FDA-2005-P-0436,"HFA-305 to Vigconic (International), Ltd.",Other,ACK-Acknowledgement Letter,2005-12-20T05:00:00Z,2005,12,,,2008-04-12T00:10:37Z,,0,0,090000648045046b
FDA-1999-N-0113-0174,FDA,FDA-1999-N-0113,"Transcript of the August 13, 2005 Meeting",Other,TR-Transcript,2005-12-20T05:00:00Z,2005,12,,,2008-04-25T00:17:45Z,,0,0,09000064804ae8c5
FDA-1999-N-0113-0175,FDA,FDA-1999-N-0113,"Transcript of the August 13, 2005 Meeting",Other,TR-Transcript,2005-12-20T05:00:00Z,2005,12,,,2008-04-25T00:17:46Z,,0,0,09000064804ae8c6
FDA-2005-P-0366-0002,FDA,FDA-2005-P-0366,Acknowledgement Letter from FDA DDM to Keller and Heckman LLP,Other,Acknowledgement Letter/Receipt,2005-12-20T05:00:00Z,2005,12,,,2025-04-24T18:29:38Z,,0,0,090000648044af31
FDA-2005-P-0366-0001,FDA,FDA-2005-P-0366,Acknowledgement Letter from FDA DDM to Keller and Heckman LLP,Other,Acknowledgement Letter/Receipt,2005-12-20T00:00:00Z,2005,12,,,2025-05-09T01:17:11Z,,0,0,090000648044aec8
FDA-2005-P-0070-0005,FDA,FDA-2005-P-0070,Acknowledgment Letter from FDA DDM to Scientific Laboratory Products,Other,Acknowledgement Letter/Receipt,2005-12-19T05:00:00Z,2005,12,,,2024-12-13T15:10:16Z,,0,0,090000648043f2f3
FDA-2005-P-0124-0003,FDA,FDA-2005-P-0124,"Letter from FDA CDER to Pharmaceutical Patent Attorneys, LLC",Other,LET-Letter,2005-12-16T05:00:00Z,2005,12,,,2024-12-13T15:34:04Z,,0,0,090000648043fc3d
FDA-2005-N-0281-0007,FDA,FDA-2005-N-0281,"Agenda for December 7-8, 2005 Hearing",Other,LST-List,2005-12-16T05:00:00Z,2005,12,,,2008-04-11T23:53:34Z,,0,0,0900006480444c01
FDA-2005-N-0281-0009,FDA,FDA-2005-N-0281,List of Attendees for 12/7-8/2005 Public Meeting,Other,LST-List,2005-12-16T05:00:00Z,2005,12,,,2008-04-11T23:53:48Z,,0,0,0900006480444c17
FDA-2005-N-0281-0006,FDA,FDA-2005-N-0281,"Agenda for December 7-8, 2005 Hearing",Other,LST-List,2005-12-16T05:00:00Z,2005,12,,,2008-04-11T23:53:36Z,,0,0,0900006480444c00
FDA-2005-N-0281-0008,FDA,FDA-2005-N-0281,"Director, Center for Drugs Evaluation and Research, FDA",Other,TS-Testimony,2005-12-16T05:00:00Z,2005,12,,,2008-04-11T23:53:31Z,,0,0,0900006480444c02
FDA-2005-P-0061-0003,FDA,FDA-2005-P-0061,Letter from FDA CFSAN to Alaska Birch Syrupmakers Association,Other,LET-Letter,2005-12-16T05:00:00Z,2005,12,,,2024-12-16T21:58:23Z,,0,0,090000648043f0ff
FDA-2005-N-0099-0017,FDA,FDA-2005-N-0099,"Transcript of the November 14, 2005 meeting",Other,TR-Transcript,2005-12-15T05:00:00Z,2005,12,,,2008-04-11T23:50:03Z,,0,0,090000648043f859
FDA-2005-P-0122-0002,FDA,FDA-2005-P-0122,Acknowledgement Letter from FDA DDM to Buchanan Ingersoll PC,Other,Acknowledgement Letter/Receipt,2005-12-15T05:00:00Z,2005,12,,,2025-04-24T14:52:02Z,,0,0,090000648043fc06
FDA-2005-P-0122-0001,FDA,FDA-2005-P-0122,Acknowledgement Letter from FDA DDM to Buchanan Ingersoll PC,Other,Acknowledgement Letter/Receipt,2005-12-15T05:00:00Z,2005,12,,,2025-04-24T14:49:23Z,,0,0,090000648043fbf1
FDA-2005-N-0040-0004,FDA,FDA-2005-N-0040,"Transcript of November 17, 2005 Meeting",Other,TR-Transcript,2005-12-14T05:00:00Z,2005,12,,,2008-04-11T23:49:32Z,,0,0,090000648043eab3
FDA-2005-N-0162-0037,FDA,FDA-2005-N-0162,"Transcript of the November 1, 2005 Public Hearing",Other,TR-Transcript,2005-12-14T05:00:00Z,2005,12,,,2008-04-11T23:50:50Z,,0,0,0900006480440836
FDA-2005-N-0040-0003,FDA,FDA-2005-N-0040,"Transcript of November 17, 2005 Meeting",Other,TR-Transcript,2005-12-14T05:00:00Z,2005,12,,,2008-04-11T23:49:32Z,,0,0,090000648043eab2
FDA-2005-N-0040-0002,FDA,FDA-2005-N-0040,"Transcript of November 17, 2005 Meeting",Other,TR-Transcript,2005-12-14T05:00:00Z,2005,12,,,2008-04-11T23:49:32Z,,0,0,090000648043eab1
FDA-1990-S-0006-0147,FDA,FDA-1990-S-0006,Statistical Report - Month of November 2005,Other,RPT-Report (outside of agency unless indicated),2005-12-14T05:00:00Z,2005,12,,,2008-05-16T23:52:04Z,,0,0,09000064805260ed
FDA-2005-N-0162-0038,FDA,FDA-2005-N-0162,"Transcript of the November 1, 2005 Public Hearing",Other,TR-Transcript,2005-12-14T05:00:00Z,2005,12,,,2008-04-11T23:50:33Z,,0,0,0900006480440837
FDA-2005-V-0148-0002,FDA,FDA-2005-V-0148,Duplicate - Acknowledgement Letter to Fullhouse Productions L.L.C.,Other,Acknowledgement Letter/Receipt,2005-12-14T05:00:00Z,2005,12,,,2025-11-06T01:19:41Z,,0,0,09000064804400b1
FDA-2004-P-0154-0004,FDA,FDA-2004-P-0154,Citizen Petition Denial Letter from FDA CFSAN to Antonio Zamora,Other,Denial of Petition,2005-12-14T05:00:00Z,2005,12,2005-12-12T05:00:00Z,,2024-11-21T22:08:44Z,,0,0,0900006480470013
FDA-2005-V-0148-0001,FDA,FDA-2005-V-0148,Acknowledgement Letter to Fullhouse Productions L.L.C.,Other,Acknowledgement Letter/Receipt,2005-12-14T05:00:00Z,2005,12,,,2025-11-06T01:17:41Z,,0,0,09000064804400a1
FDA-2001-D-0092-0022,FDA,FDA-2001-D-0092,Clinical Laboratory Improvement Advisory Committee,Other,Supplement (SUP),2005-12-12T05:00:00Z,2005,12,,,2025-09-18T19:16:10Z,,0,0,09000064804b8ded
FDA-2001-D-0092-0023,FDA,FDA-2001-D-0092,Clinical Laboratory Improvement Advisory Committee,Other,Supplement (SUP),2005-12-12T05:00:00Z,2005,12,,,2025-09-18T19:17:15Z,,0,0,09000064804b8def
FDA-1976-N-0519-0008,FDA,FDA-1976-N-0519,"Acknowledgement Letter from FDA/DDM to Foley & Lardner, LLP",Other,Acknowledgement Letter/Receipt,2005-12-09T05:00:00Z,2005,12,,,2016-02-23T21:34:28Z,,0,0,090000648053bd53
FDA-2005-P-0126-0003,FDA,FDA-2005-P-0126,Letter from FDA CFSAN to David J Getoff,Other,Letter(s),2005-12-09T05:00:00Z,2005,12,,,2025-03-14T12:38:18Z,,0,0,090000648043fc6d
FDA-1976-N-0519-0007,FDA,FDA-1976-N-0519,"Acknowledgement Letter from FDA/DDM to Foley & Lardner, LLP",Other,Acknowledgement Letter/Receipt,2005-12-09T05:00:00Z,2005,12,,,2016-03-08T16:10:22Z,,0,0,090000648053bd52
FDA-2005-N-0099-0011,FDA,FDA-2005-N-0099,"Director, Center for Drug Evaluation and Research, FDA",Other,TS-Testimony,2005-12-07T05:00:00Z,2005,12,,,2008-04-11T23:50:04Z,,0,0,090000648043f828
FDA-2005-N-0099-0012,FDA,FDA-2005-N-0099,"Director, Center for Drug Evaluation and Research, FDA",Other,TS-Testimony,2005-12-07T05:00:00Z,2005,12,,,2008-04-11T23:50:03Z,,0,0,090000648043f829
FDA-2005-N-0099-0005,FDA,FDA-2005-N-0099,"Agenda for November 14, 25005 FDA and Stateholders Public Meeting",Other,LST-List,2005-12-07T05:00:00Z,2005,12,,,2008-04-11T23:50:03Z,,0,0,090000648043f822
FDA-2005-N-0099-0013,FDA,FDA-2005-N-0099,"Director, Center for Biologics Evaluation and Research, FDA",Other,TS-Testimony,2005-12-07T05:00:00Z,2005,12,,,2008-04-11T23:50:03Z,,0,0,090000648043f82a
FDA-2005-P-0062-0002,FDA,FDA-2005-P-0062,Acknowledgment Letter from FDA DDM to U.S. Public Interest Research Group,Other,Acknowledgement Letter/Receipt,2005-12-07T05:00:00Z,2005,12,,,2025-04-24T13:34:58Z,,0,0,090000648043f11a
FDA-2005-N-0099-0015,FDA,FDA-2005-N-0099,"Deputy Commissioner for Policy, FDA",Other,TS-Testimony,2005-12-07T05:00:00Z,2005,12,,,2008-04-11T23:50:03Z,,0,0,090000648043f839
FDA-2005-N-0099-0016,FDA,FDA-2005-N-0099,"Deputy Commissioner for Policy, FDA",Other,TS-Testimony,2005-12-07T05:00:00Z,2005,12,,,2008-04-11T23:50:03Z,,0,0,090000648043f83a
FDA-2005-N-0099-0014,FDA,FDA-2005-N-0099,"Director, Center for Biologics Evaluation and Research, FDA",Other,TS-Testimony,2005-12-07T05:00:00Z,2005,12,,,2008-04-11T23:50:03Z,,0,0,090000648043f82b
FDA-2005-N-0099-0008,FDA,FDA-2005-N-0099,"Biographies for November 14, 2005 Meeting",Other,LST-List,2005-12-07T05:00:00Z,2005,12,,,2008-04-11T23:50:03Z,,0,0,090000648043f825
FDA-2000-V-0070-0002,FDA,FDA-2000-V-0070,Approval for Variance from FDA to Insight Technology Inc,Other,Approval for Variance (VRA),2005-12-07T05:00:00Z,2005,12,,,2025-08-11T21:50:52Z,,0,0,09000064804b0204
FDA-2005-N-0099-0007,FDA,FDA-2005-N-0099,"Biographies for November 14, 2005 Meeting",Other,LST-List,2005-12-07T05:00:00Z,2005,12,,,2008-04-11T23:50:03Z,,0,0,090000648043f824
FDA-2005-N-0099-0006,FDA,FDA-2005-N-0099,"Agenda for November 14, 25005 FDA and Stateholders Public Meeting",Other,LST-List,2005-12-07T05:00:00Z,2005,12,,,2008-04-11T23:50:03Z,,0,0,090000648043f823
FDA-2005-N-0099-0009,FDA,FDA-2005-N-0099,"Deputy Commissioner for Operations, FDA",Other,TS-Testimony,2005-12-07T05:00:00Z,2005,12,,,2008-04-11T23:50:03Z,,0,0,090000648043f826
FDA-2005-P-0062-0001,FDA,FDA-2005-P-0062,Acknowledgment Letter from FDA DDM to U.S. Public Interest Research Group,Other,Acknowledgement Letter/Receipt,2005-12-07T05:00:00Z,2005,12,,,2025-04-24T13:33:27Z,,0,0,090000648043f115
FDA-2005-N-0099-0010,FDA,FDA-2005-N-0099,"Deputy Commissioner for Operations, FDA",Other,TS-Testimony,2005-12-07T05:00:00Z,2005,12,,,2008-04-11T23:50:03Z,,0,0,090000648043f827
FDA-2005-N-0281-0005,FDA,FDA-2005-N-0281,Embassy of France / Economic Department,Other,APE-Appearance Request,2005-12-06T05:00:00Z,2005,12,,,2008-04-11T23:53:34Z,,0,0,0900006480444bec
FDA-1987-V-0006-0002,FDA,FDA-1987-V-0006,Variance Approval Letter from FDA CDRH to Chameleon Productions,Other,Approval for Variance (VRA),2005-12-06T05:00:00Z,2005,12,,,2023-05-01T13:29:23Z,,0,0,090000648046b708
FDA-2004-H-0391-0108,FDA,FDA-2004-H-0391,FDA/DDM to Parties,Other,CS-Certificate of Service,2005-12-05T05:00:00Z,2005,12,,,2008-04-12T00:37:52Z,,0,0,0900006480474361
FDA-2005-P-0067-0003,FDA,FDA-2005-P-0067,"Letter from FDA CDRH to Zuckerman Spaeder, LLP",Other,LET-Letter,2005-12-05T05:00:00Z,2005,12,,,2024-11-18T17:18:00Z,,0,0,090000648043f298
FDA-2004-H-0391-0109,FDA,FDA-2004-H-0391,FDA/DDM to Parties,Other,CS-Certificate of Service,2005-12-05T05:00:00Z,2005,12,,,2008-04-12T00:37:52Z,,0,0,0900006480474362
FDA-2004-H-0391-0106,FDA,FDA-2004-H-0391,"Center for Devices and Radiological Health, Ecumed Health Group, Inc, Amador Reyes, Juan Carrai, Ric",Other,MO-Motion,2005-12-05T05:00:00Z,2005,12,,,2008-04-12T00:37:50Z,,0,0,090000648047435f
FDA-2004-H-0391-0107,FDA,FDA-2004-H-0391,Administrative Law Judge,Other,OR-Order,2005-12-05T05:00:00Z,2005,12,,,2008-04-12T00:37:52Z,,0,0,0900006480474360
FDA-2004-P-0471-0005,FDA,FDA-2004-P-0471,Citizen Petition Denial from FDA CFSAN to Bunny Abraham,Other,Denial of Petition,2005-12-05T05:00:00Z,2005,12,2005-11-21T05:00:00Z,,2025-03-18T20:39:33Z,,0,0,0900006480475c61
FDA-2005-D-0208-0002,FDA,FDA-2005-D-0208,"Guidance for Industry: Safety, Efficacy, and Pharmacokinetic Studies to Support Marketing of Immune Globulin Intravenous (Human) as Replacement Therapy for Primary Humoral Immunodeficiency; Draft Guidance Document",Other,GDL-Guidance (Supporting and Related Materials),2005-12-02T05:00:00Z,2005,12,,,2008-07-18T05:20:46Z,,0,0,090000648044123a
FDA-2005-H-0506-0020,FDA,FDA-2005-H-0506,"HF-3 to TMJ Implants, Inc.",Other,OR-Order,2005-12-01T05:00:00Z,2005,12,,,2008-04-11T23:48:21Z,,0,0,0900006480464430
FDA-2005-H-0506-0021,FDA,FDA-2005-H-0506,FDA/DDM,Other,CS-Certificate of Service,2005-12-01T05:00:00Z,2005,12,,,2008-04-11T23:48:27Z,,0,0,0900006480464431
FDA-2005-H-0506-0018,FDA,FDA-2005-H-0506,"HF-3 to TMJ Implants, Inc.",Other,OR-Order,2005-12-01T05:00:00Z,2005,12,,,2008-04-11T23:48:22Z,,0,0,090000648046442e
FDA-2005-H-0506-0019,FDA,FDA-2005-H-0506,FDA/DDM,Other,CS-Certificate of Service,2005-12-01T05:00:00Z,2005,12,,,2008-04-11T23:48:22Z,,0,0,090000648046442f
FDA-2005-P-0433-0005,FDA,FDA-2005-P-0433,Letter from FDA CFSAN to City of Allentown Health Bureau,Other,LET-Letter,2005-11-29T05:00:00Z,2005,11,,,2024-11-18T16:25:42Z,,0,0,09000064804503dc
FDA-2003-P-0335-0004,FDA,FDA-2003-P-0335,"Letter from FDA CDER to Fulcrum, Inc.",Other,LET-Letter,2005-11-29T05:00:00Z,2005,11,2005-11-28T05:00:00Z,,2024-11-20T22:10:59Z,,0,0,09000064804960bb
FDA-2005-H-0506-0017,FDA,FDA-2005-H-0506,"GCF-1, TMJ Implants, Inc. and Robert W. Christensen and Maureen K . Mooney",Other,MO-Motion,2005-11-29T05:00:00Z,2005,11,,,2008-04-11T23:48:24Z,,0,0,090000648046442a
FDA-2004-G-0002-0005,FDA,FDA-2004-G-0002,"Guidance for Industry and FDA Staff: Guidance for Records Access Authority Provided in Title III, Subtitle A, of the Public Health Security and Bioterrorism Preparedness and Response Act of 2002",Other,Guidance,2005-11-29T05:00:00Z,2005,11,2020-09-16T04:00:00Z,,2024-11-06T23:39:58Z,,1,0,090000648485cceb
FDA-2005-N-0295-0002,FDA,FDA-2005-N-0295,"Agenda - ""Assessing Consumer Perceptions of Health Claims, November 17, 2005"" - Public Meeting",Other,LST-List,2005-11-25T05:00:00Z,2005,11,,,2013-08-11T02:31:58Z,,0,0,0900006480446b2d
FDA-2005-N-0295-0012,FDA,FDA-2005-N-0295,"Federal Trade Commission (FTC) (PIppolito) - ""Qualified Health Claims"" - [Assessing Consumer Perceptions of Health Claims; Public Meeting; Request for Comments] - Testimony",Other,TS-Testimony,2005-11-25T05:00:00Z,2005,11,,,2010-03-19T15:56:48Z,,0,0,0900006480446b49
FDA-2005-P-0329-0002,FDA,FDA-2005-P-0329,Acknowledgement Letter from FDA DDM to Camargo Pharmaceutical Services,Other,Acknowledgement Letter/Receipt,2005-11-25T05:00:00Z,2005,11,,,2025-04-24T12:20:39Z,,0,0,09000064804486b4
FDA-2005-N-0295-0005,FDA,FDA-2005-N-0295,"FDA/CFSAN/ONPLDS (BSchneeman) - ""Scientific Review of Qualified Health Claims (QHC)"" - [Assessing Consumer Perceptions of Health Claims; Public Meeting; Request for Comments] - Testimony",Other,TS-Testimony,2005-11-25T05:00:00Z,2005,11,,,2013-07-28T01:32:19Z,,0,0,0900006480446b34
FDA-2005-P-0329-0001,FDA,FDA-2005-P-0329,Acknowledgement Letter from FDA DDM to Camargo Pharmaceutical Services,Other,Acknowledgement Letter/Receipt,2005-11-25T05:00:00Z,2005,11,,,2025-04-24T12:19:27Z,,0,0,0900006480448649
FDA-2005-N-0295-0003,FDA,FDA-2005-N-0295,"FDA Office of the General Counsel (LNickerson) - ""Legal Context of Consumer Research on Health Claims and Other Food Labeling Claims"" - [Assessing Consumer Perceptions of Health Claims; Public Meeting; Request for Comments] - Testimony",Other,TS-Testimony,2005-11-25T05:00:00Z,2005,11,,,2013-07-27T20:43:22Z,,0,0,0900006480446b2f
FDA-2005-N-0295-0007,FDA,FDA-2005-N-0295,"FDA/CFSAN (SBradbard) - ""Consumer Studies Research Overview"" - [Assessing Consumer Perceptions of Health Claims; Public Meeting; Request for Comments] - Testimony",Other,TS-Testimony,2005-11-25T05:00:00Z,2005,11,,,2013-08-11T02:31:58Z,,0,0,0900006480446b3b
FDA-2005-N-0295-0010,FDA,FDA-2005-N-0295,"FDA, Office of Regulatory Affairs (BDerby) - ""Effects of Strength of Science Disclaimers on the Communication Impacts of Health Claims"" - [Assessing Consumer Perceptions of Health Claims; Public Meeting; Request for Comments] - Testimony",Other,TS-Testimony,2005-11-25T05:00:00Z,2005,11,,,2013-07-27T20:43:23Z,,0,0,0900006480446b43